
CND to present updates from three clinical trials involving their skin biopsy diagnostic tool for dementia and other ...
CND Life Sciences (CND) announced that three abstracts related to changes in cutaneous phosphorylated alpha-synuclein (P-SYN) in patients with dementia with Lewy bodies (DLB) and other related disorders will be presented at the American Academy of …